Common Contracts

COMMERCIAL LICENSE AGREEMENT

Commercial License Agreement • June 19th, 2020 • Poseida Therapeutics, Inc. • Biological products, (no disgnostic substances) • California

• Contract Type
  Commercial License Agreement
• Filed
  June 19th, 2020
• Company
  Poseida Therapeutics, Inc.
• Industry
  Biological products, (no disgnostic substances)
• Jurisdiction
  California

This Commercial License Agreement (“Agreement”) is entered into effective August 3, 2018 (“Effective Date”) by TeneoBio, Inc. (“TeneoBio”), having its principal place of business at 1490 O’Brien Drive, Suite D, Menlo Park, CA 94025, and Poseida Therapeutics, Inc. (“Licensee”), having its principal place of business at 4242 Campus Point Court, #700, San Diego, CA 92121. In consideration of the mutual covenants and promises set forth in this Agreement, the parties agree as follows:

COMMERCIAL LICENSE AGREEMENT

Commercial License Agreement • April 17th, 2020 • Poseida Therapeutics, Inc. • Biological products, (no disgnostic substances) • California

• Contract Type
  Commercial License Agreement
• Filed
  April 17th, 2020
• Company
  Poseida Therapeutics, Inc.
• Industry
  Biological products, (no disgnostic substances)
• Jurisdiction
  California

This Commercial License Agreement (“Agreement”) is entered into effective August 3, 2018 (“Effective Date”) by TeneoBio, Inc. (“TeneoBio”), having its principal place of business at 1490 O’Brien Drive, Suite D, Menlo Park, CA 94025, and Poseida Therapeutics, Inc. (“Licensee”), having its principal place of business at 4242 Campus Point Court, #700, San Diego, CA 92121. In consideration of the mutual covenants and promises set forth in this Agreement, the parties agree as follows:

COMMERCIAL LICENSE AGREEMENT

Commercial License Agreement • January 4th, 2019 • Poseida Therapeutics, Inc. • Biological products, (no disgnostic substances) • California

• Contract Type
  Commercial License Agreement
• Filed
  January 4th, 2019
• Company
  Poseida Therapeutics, Inc.
• Industry
  Biological products, (no disgnostic substances)
• Jurisdiction
  California

This Commercial License Agreement (“Agreement”) is entered into effective August 3, 2018 (“Effective Date”) by TeneoBio, Inc. (“TeneoBio”), having its principal place of business at 1490 O’Brien Drive, Suite D, Menlo Park, CA 94025, and Poseida Therapeutics, Inc. (“Licensee”), having its principal place of business at 4242 Campus Point Court, #700, San Diego, CA 92121. In consideration of the mutual covenants and promises set forth in this Agreement, the parties agree as follows: